COVID 19 Antibodies for IgG, IgA, and IgM - KSL Chemiluminescence Assay
- GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000593853.1
- Last updated: 2021-08-25
- Annual Review past due read more
- Test version history
- 593853.1, last updated: 2021-08-25
Clinical microbial testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for COVID-19
Offered by KSL Diagnostics
Overview
Test name
HelpThe name the laboratory assigns the test. Used as the default title of the page specific to the test.COVID 19 Antibodies for IgG, IgA, and IgM - KSL Chemiluminescence Assay
This is a clinical microbial test intended for HelpPurposes or indications for the test. Lab-provided.: Screening
Click Indication tab for more information.
Online through physician request drawn at the office or in one of our collection sites
CPT Code: 86769 x3
Order URL HelpLink to the laboratory webpage with information about how to order this test. Please note that clicking on this link will open a new tab in your internet browser.: https://www.ksldx.com/covid-19-antibody-test
Specimen source
Sample requirements
Serum or plasma samples are recommended. The recommended protocol for novel coronavirus inactivation: 1) 56°C for 30 min or 2) Disinfectant: (Fat solvents such as diethyl ether, 75% ethyl alcohol, bleach, peracetic acid, chloroform). Avoid using hemolytic specimen, lipemic specimen, icteric specimens and polluted specimen. Sera samples can be temporarily stored at - 20°C for no longer than 8 months.Turnaround time
24-48 hoursMethodology
HelpThe assay's major method category (biochemical, cytogenetic or molecular genetics); method category (i.e. enzyme assay, chromosome breakage studies, targeted mutation analysis); methodology (i.e. the name of the method used) and instruments used when performing this test.- Serology
- OAntibody assay
- Chemiluminescent Immunoassay (CIA)
Not provided
Clinical validity
HelpHow consistently and accurately the test detects or predicts the intermediate or final outcomes of interest. Lab-provided.Not provided
Comments about the test interpretation (e.g. clinical implication of test results)
Positive results to antibodies against SARS-CoV-2 are generally indicative of an individual’s current or prior infection with the SARS-Cov-2 virus. However, the duration of these antibodies remaining in circulation has not yet been established. These test results should always be considered in the context of a patient’s clinical history, physical examination, epidemiologic exposures, and vaccination history before making the final diagnosis. IgM isotype antibodies develop within 5 to 7 days indicating recent exposure to the virus. IgG isotype antibodies develop after 10 days and remain in circulation longer. It may indicate past exposure or vaccine mediated immune response. IgA isotype antibody development is variable in its response and may indicate past exposure or vaccine-mediated immune response.IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.